Search

everythinglearnresearchcommunity

for

Search:↓

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

Hair loss doesn't affect COVID-19 severity.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Caraway, Chinese chives, and cassia may improve health and prevent diseases due to their nutrients and medicinal properties.

People in Jeddah know about Vitamin D and its sources but are unclear on how much they need daily, and while many women take supplements, attitudes towards increasing Vitamin D levels vary.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

The pandemic changed how often certain skin conditions were diagnosed.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

Doctors should thoroughly inform hair transplant patients about the procedure, risks, and costs to prevent dissatisfaction and legal issues.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Children's screen time increased during the pandemic, causing various health issues.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Netherton syndrome can cause severe dehydration, infections, and growth issues in infants.